» Articles » PMID: 9366296

Quality of Life for Adult Leukemia Survivors Treated on Clinical Trials of Cancer and Leukemia Group B During the Period 1971-1988: Predictors for Later Psychologic Distress

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1997 Nov 20
PMID 9366296
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To identify predictors of psychosocial adjustment for survivors of adult acute leukemia, the adaptation of 206 survivors (77% with acute myelogenous leukemia, and 23% with acute lymphocytic leukemia) treated on any of 13 Cancer and Leukemia Group B trials during the period 1971-1988 was examined.

Methods: Survivors (median age, 41 years) who were at least 1 year from completion of all treatment (median, 5 years) were interviewed by telephone about psychologic symptoms; social, sexual, and vocational function; and beliefs about control over health. Standardized psychologic instruments were used to evaluate survivors' responses.

Results: Most survivors adapted well; however, 14% were 1.5 standard deviations above normal on the Global Severity Index of the Brief Symptom Inventory. Predictors of greater psychologic distress included less education, younger age, anticipatory distress during chemotherapy treatment, and the combination of more medical problems after treatment with poorer family function. Anticipatory nausea and distress during chemotherapy predicted persistent visceral distress later, which occurred with reminders of treatment. Anticipatory vomiting predicted a greater tendency toward cancer-related intrusive thoughts and avoidance of reminders.

Conclusions: Patients experiencing anticipatory distress during treatment who are younger and less educated should be monitored for depressive syndromes later.

Citing Articles

Fear of Cancer Recurrence and Fear of Cancer Progression, Digital Resource Engagement and Health Literacy: A Review.

Kenny-Jones M, Nankivell P, Mehanna H, Ozakinci G Curr Oncol. 2024; 31(12):7586-7602.

PMID: 39727682 PMC: 11674502. DOI: 10.3390/curroncol31120559.


Digital intervention (Renewed) to support symptom management, wellbeing, and quality of life among cancer survivors in primary care: a randomised controlled trial.

Little P, Bradbury K, Stuart B, Barnett J, Krusche A, Steele M Br J Gen Pract. 2024; .

PMID: 38164562 PMC: 11755581. DOI: 10.3399/BJGP.2023.0262.


Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.

McErlean G, Tapp C, Brice L, Gilroy N, Kabir M, Greenwood M BMC Psychol. 2023; 11(1):235.

PMID: 37587508 PMC: 10433676. DOI: 10.1186/s40359-023-01204-4.


Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey.

McErlean G, Tapp C, Brice L, Pradhan A, Gilroy N, Kabir M Clin Nurs Res. 2023; 32(8):1134-1144.

PMID: 37329124 PMC: 10504814. DOI: 10.1177/10547738231180337.


Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.

Osann K, Wenzel L, McKinney C, Wagner L, Cella D, Fulci G Gynecol Oncol. 2023; 171:151-158.

PMID: 36905875 PMC: 10681156. DOI: 10.1016/j.ygyno.2023.02.015.